独活寄生汤联合化学药治疗强直性脊柱炎疗效的Meta分析

摘要

OBJECTIVE:To systematically review the efficacy of Duhuo jisheng decoction combined with chemical medicines in the treatment of ankylosing spondylitis (AS),and to provide reference for clinical treatment. METHODS:Retrieved from CBM,CJFD,VIP,Wanfang Database,PubMed and EMBase,randomized controlled trials(RCT)about Duhuo jisheng decoction combined with chemical medicines(test group)versus chemical medicines alone(control group)in the treatment of AS were col-lected,Meta-analysis was performed by using Rev Man 5.3 software after data extraction and quality evaluation. RESULTS:Total-ly 6 RCTs were included,involving 382 patients. Results of Meta-analysis showed,the total effective rate [RR=1.35,95%CI(1.20, 1.52),P<0.001],improvement rate of TCM symptoms [RR=1.31,95%CI(1.09,1.57),P=0.004)in test group were significantly higher than control group,and CRP level was lower than contxol group[MD=-6.18,95%CI(-8.49,-3.87),P<0.001],the dif-ference was statistically significant. CONCLUSIONS:Duhuo jisheng decoction combined with chemical medicines shows better effi-cacy than chemical medicines alone,it can improve the TCM symptoms and decrease the CRP level.%目的：系统评价独活寄生汤联合化学药治疗强直性脊柱炎（AS）的疗效，为临床提供循证参考。方法：计算机检索中国生物医学文献数据库、中国期刊全文数据库、中文科技期刊数据库、万方数据库、PubMed、EMBase，纳入独活寄生汤联合化学药（试验组）对比单用化学药（对照组）治疗AS的随机对照试验（RCT），提取资料并评价质量，采用Rev Man 5.3统计软件进行Meta分析。结果：共纳入6项RCT，合计382例患者。Meta分析结果显示，试验组患者有效率[RR＝1.35，95％CI（1.20，1.52），P＜0.001]、中医症候改善率[RR＝1.31，95％CI（1.09，1.57），P＝0.004]显著高于对照组，C反应蛋白（CRP）水平[MD＝－6.18，95％CI （－8.49，－3.87），P＜0.001]显著低于对照组，差异均有统计学意义。结论：独活寄生汤联合化学药治疗AS疗效优于单用化学药，可以改善患者中医症候，降低CRP水平。